These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12621638)

  • 21. Two large Polish kindreds with levodopa-responsive Parkinsonism not linked to known Parkinsonian genes and loci.
    Krygowska-Wajs A; Hussey JM; Hulihan M; Farrer MJ; Tsuboi Y; Uitti RJ; Wszolek ZK
    Parkinsonism Relat Disord; 2003 Mar; 9(4):193-200. PubMed ID: 12618053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decades of delayed diagnosis in 4 levodopa-responsive young-onset monogenetic parkinsonism patients.
    Ling H; Braschinsky M; Taba P; Lüüs SM; Doherty K; Hotter A; Poewe W; Lees AJ
    Mov Disord; 2011 Jun; 26(7):1337-40. PubMed ID: 21449012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SCA2 presenting as levodopa-responsive parkinsonism in a young patient from the United Kingdom: a case report.
    Wilkins A; Brown JM; Barker RA
    Mov Disord; 2004 May; 19(5):593-5. PubMed ID: 15133829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-associated Parkinsonism with levodopa-induced dyskinesia and response to highly-active antiretroviral therapy.
    Kobylecki C; Silverdale MA; Varma A; Dick JP; Kellett MW
    Mov Disord; 2009 Dec; 24(16):2441-2. PubMed ID: 19908326
    [No Abstract]   [Full Text] [Related]  

  • 25. Awakenings from persistent vegetative state: report of three cases with parkinsonism and brain stem lesions on MRI.
    Matsuda W; Matsumura A; Komatsu Y; Yanaka K; Nose T
    J Neurol Neurosurg Psychiatry; 2003 Nov; 74(11):1571-3. PubMed ID: 14617720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early-onset levodopa responsive parkinsonism in PPP2R5D mutation.
    Mahale R; Arunachal G; Chadha D; Padmanabha H; M P; Pavagada M
    Parkinsonism Relat Disord; 2024 Jun; 123():106952. PubMed ID: 38582018
    [No Abstract]   [Full Text] [Related]  

  • 27. Levodopa-responsive parkinsonism in a patient with corticobasal degeneration and bilateral choroid plexus xanthogranulomas.
    Lu JQ; Fong C; Attar A
    J Clin Neurosci; 2020 Jan; 71():286-289. PubMed ID: 31537463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levodopa responsiveness in disorders with parkinsonism: a review of the literature.
    Constantinescu R; Richard I; Kurlan R
    Mov Disord; 2007 Nov; 22(15):2141-8; quiz 2295. PubMed ID: 17534959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dramatic Response to Pramipexole in Delayed-Onset Parkinsonism from Osmotic Demyelinating Syndrome.
    Han SC; Katus L; Frucht S
    Tremor Other Hyperkinet Mov (N Y); 2020 Jun; 10():9. PubMed ID: 32775023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levodopa-responsive parkinsonism associated with hydrocephalus.
    Kim MJ; Chung SJ; Sung YH; Lee MC; Im JH
    Mov Disord; 2006 Aug; 21(8):1279-81. PubMed ID: 16639728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel compound heterozygous synaptojanin-1 mutation causes l-dopa-responsive dystonia-parkinsonism syndrome.
    Rauschendorf MA; Jost M; Stock F; Zimmer A; Rösler B; Rijntjes M; Piroth T; Coenen VA; Reinacher PC; Meyer PT; Frings L; Weiller C; Fischer J; Klebe S
    Mov Disord; 2017 Mar; 32(3):478-480. PubMed ID: 27869329
    [No Abstract]   [Full Text] [Related]  

  • 32. Pediatric Gaucher disease with intermediate type 2-3 phenotype associated with parkinsonian features and levodopa responsiveness.
    Darling A; Irún P; Giraldo P; Armstrong J; Gort L; Díaz-Conradi Á; Yubero D; De Oryazábal Sanz AL; Ormazábal A; Artuch R; García-Cazorla À; O'Callaghan M
    Parkinsonism Relat Disord; 2021 Oct; 91():19-22. PubMed ID: 34454394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. POLG1-related levodopa-responsive parkinsonism.
    Miguel R; Gago MF; Martins J; Barros P; Vale J; Rosas MJ
    Clin Neurol Neurosurg; 2014 Nov; 126():47-54. PubMed ID: 25203713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A possible association between exposure to n-hexane and parkinsonism.
    Vanacore N; Gasparini M; Brusa L; Meco G
    Neurol Sci; 2000 Feb; 21(1):49-52. PubMed ID: 10938202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small (autonomic) and large fiber neuropathy in Parkinson disease and parkinsonism.
    de Araújo DF; de Melo Neto AP; Oliveira ÍS; Brito BS; de Araújo IT; Barros IS; Lima JW; Horta WG; Gondim Fde A
    BMC Neurol; 2016 Aug; 16():139. PubMed ID: 27530902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New nonsense mutation in the GTP-cyclohydrolase I gene in L-DOPA responsive dystonia-parkinsonism.
    Hoenicka J; Vidal L; Godoy M; Ochoa JJ; García de Yébenes J
    Mov Disord; 2001 Mar; 16(2):364-6. PubMed ID: 11295799
    [No Abstract]   [Full Text] [Related]  

  • 37. Do levodopa treatments modify the morphology of the parkinsonian brain?
    Vernon AC; Modo M
    Mov Disord; 2012 Jan; 27(1):166-7. PubMed ID: 22076912
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of Parkinsonism: collaboration between the physician and the neurologist].
    Vingerhoets F
    Rev Med Suisse Romande; 2000 Sep; 120(9):709-16. PubMed ID: 11094535
    [No Abstract]   [Full Text] [Related]  

  • 39. Reversible parkinsonism following ventriculoperitoneal shunt in a patient with obstructive hydrocephalus secondary to intraventricular neurocysticercosis.
    Prashantha DK; Netravathi M; Ravishankar S; Panda S; Pal PK
    Clin Neurol Neurosurg; 2008 Jul; 110(7):718-21. PubMed ID: 18440127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of the novel aminoadamantane derivative A-7 on Parkinsonian syndrome induced by systemic administration of neurotoxin MPTP].
    Nerobkova LN; Val'dman EA; Voronina TA; Markina NV; Sharkova LM
    Eksp Klin Farmakol; 2000; 63(3):3-6. PubMed ID: 10934586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.